Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Prosecution Will Continue Under False Claims Act, Kickback Laws

Executive Summary

Medco's handling of mail-order services as a subcontractor to the Blue Cross Blue Shield Association for the Federal Employees Health Benefit Program is liable to prosecution under the False Claims Act, a Philadelphia federal court judge ruled Sept. 23

You may also be interested in...



Medco/Merck Contract Gets New Spin; Renegotiation May Avert Zocor Impact

Medco's renegotiation of its rebate agreement with Merck may have allowed the pharmacy benefit manager to avoid loss of rebates accompanying Zocor'slooming patent expiration

Medco/Merck Contract Gets New Spin; Renegotiation May Avert Zocor Impact

Medco's renegotiation of its rebate agreement with Merck may have allowed the pharmacy benefit manager to avoid loss of rebates accompanying Zocor'slooming patent expiration

Zocor, Zoloft And Pravachol Will Be Key Generic Switches For Medco In ’06

Medco sees a significant opportunity for growth in 2006 generic switches, Group President-National Accounts Timothy Wentworth says

Related Content

Topics

UsernamePublicRestriction

Register

PS044719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel